Synthetic peptide conjugated to KLH, corresponding to a region within N terminal amino acids 50-80 of Human TMEM30B
- MDA-MB435, Human breast carcinoma
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Immunogen affinity purified
This antibody is purified through a protein A column, followed by peptide affinity purification.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/100 - 1/500. Predicted molecular weight: 39 kDa.
||1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Belongs to the CDC50/LEM3 family.
Information by UniProt
- 9130011B11Rik antibody
- CC50B_HUMAN antibody
- CDC50, S. cerevisiae, homolog of, B antibody
Western blot - TMEM30B antibody (ab104105)
Anti-TMEM30B antibody (ab104105) at 1/100 dilution + MDA-MB435 cell lysate at 35 µg
Predicted band size : 39 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - TMEM30B antibody (ab104105)
IHC analysis in formalin fixed and
paraffin embedded Human breast carcinoma followed by peroxidase conjugation
of the secondary antibody and DAB staining, using ab104105 at a dilution of 1/50.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"